Aurinia Pharmaceuticals Inc
(STU:IKAP)
€
6.04
0.136 (2.3%)
Market Cap: 869.55 Mil
Enterprise Value: 649.61 Mil
PE Ratio: 0
PB Ratio: 2.65
GF Score: 77/100 Aurinia Pharmaceuticals Inc (STU:IKAP) Transcripts
- Q2 2024 Aurinia Pharmaceuticals Inc Earnings Call TranscriptAug 01, 2024€5.39 (-1.43%)Earnings
- Q1 2024 Aurinia Pharmaceuticals Inc Earnings Call TranscriptMay 02, 2024€4.76 (-0.17%)Earnings
- Q4 2023 Aurinia Pharmaceuticals Inc Earnings Call TranscriptFeb 15, 2024€7.82 (+8.31%)Earnings
- Q3 2023 Aurinia Pharmaceuticals Inc Earnings Call TranscriptNov 02, 2023€7.35 (+10.03%)Earnings
- Q2 2023 Aurinia Pharmaceuticals Inc Earnings Call TranscriptAug 03, 2023€9.56 (+4.25%)Earnings
- Q1 2023 Aurinia Pharmaceuticals Inc Earnings Call TranscriptMay 04, 2023€10.06 (-6.16%)Earnings
- Aurinia Pharmaceuticals Inc To Discuss Renal Biopsy Substudy Top-line Results Call TranscriptApr 05, 2023
- Q4 2022 Aurinia Pharmaceuticals Inc Earnings Call TranscriptFeb 28, 2023Earnings
- Aurinia Pharmaceuticals Inc at JPMorgan Healthcare Conference TranscriptJan 12, 2023
- Q3 2022 Aurinia Pharmaceuticals Inc Earnings Call TranscriptNov 03, 2022€7.68 (+0.72%)Earnings
- Q2 2022 Aurinia Pharmaceuticals Inc Earnings Call TranscriptAug 04, 2022€8.27 (-5.69%)Earnings
- Aurinia Pharmaceuticals Inc Annual Shareholders Meeting TranscriptMay 17, 2022
- Q1 2022 Aurinia Pharmaceuticals Inc Earnings Call TranscriptMay 10, 2022€8.4 (-12.62%)Earnings
- Q4 2021 Aurinia Pharmaceuticals Inc Earnings Call TranscriptFeb 28, 2022€10.66 (-23.00%)Earnings
- Aurinia Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 13, 2022
- Aurinia Pharmaceuticals Inc Announces Positive Topline Results From the AURORA 2 Continuation Study - Corporate Call TranscriptDec 09, 2021
- Q3 2021 Aurinia Pharmaceuticals Inc Earnings Call TranscriptNov 03, 2021€27.42 (+1.52%)Earnings
- Aurinia Pharmaceuticals Inc at Cantor Fitzgerald Global Healthcare Conference (Virtual) TranscriptSep 30, 2021
- Aurinia Pharmaceuticals Inc at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit (Virtual) TranscriptSep 20, 2021
- Aurinia Pharmaceuticals Inc at H C Wainwright Global Investment Conference (Virtual) - On-Demand TranscriptSep 13, 2021
- Q2 2021 Aurinia Pharmaceuticals Inc Earnings Call TranscriptAug 05, 2021Earnings
- Aurinia Pharmaceuticals Inc Annual Shareholders Meeting TranscriptJun 07, 2021
- Q1 2021 Aurinia Pharmaceuticals Inc Earnings Call TranscriptMay 06, 2021€9.99 (-2.02%)Earnings
- Aurinia Pharmaceuticals Inc at Cowen Healthcare Conference (Virtual) TranscriptMar 04, 2021
- Q4 2020 Aurinia Pharmaceuticals Inc Earnings Call TranscriptFeb 24, 2021€11.92 (+2.23%)Earnings
- Aurinia Pharmaceuticals Inc Conference Call to Discuss LUPKYNIS Approval TranscriptJan 25, 2021
- Aurinia Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 14, 2021
- Q3 2020 Aurinia Pharmaceuticals Inc Earnings Call TranscriptNov 10, 2020€11.68 (+0.34%)Earnings
- Aurinia Pharmaceuticals Inc Clinical Trial Update TranscriptNov 02, 2020
- Q2 2020 Aurinia Pharmaceuticals Inc Earnings Call TranscriptAug 11, 2020€12.12 (-1.14%)Earnings
- Aurinia Pharmaceuticals Inc Annual Shareholders Meeting TranscriptJun 02, 2020
- Q1 2020 Aurinia Pharmaceuticals Inc Earnings Call TranscriptMay 14, 2020€16 (+0.63%)Earnings
- Aurinia Pharmaceuticals Inc. - Special Call TranscriptMar 26, 2020
- Q4 2019 Aurinia Pharmaceuticals Inc Earnings Call TranscriptMar 05, 2020€16.7 (+2.45%)Earnings
- Aurinia Pharmaceuticals Inc. - Special Call TranscriptDec 05, 2019
- Q3 2019 Aurinia Pharmaceuticals Inc Earnings Call TranscriptNov 14, 2019€4.64 (+1.75%)Earnings
- Q2 2019 Aurinia Pharmaceuticals Inc Earnings Call TranscriptAug 06, 2019€5.41 (-0.18%)Earnings
- Q1 2019 Aurinia Pharmaceuticals Inc Earnings Call TranscriptMay 14, 2019€5.37 (+0.94%)Earnings
- Q4 2018 Aurinia Pharmaceuticals Inc Earnings Call TranscriptMar 19, 2019€5.62 (+2.18%)Earnings
- 1